296 related articles for article (PubMed ID: 8666914)
1. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
Tian J; Atkinson MA; Clare-Salzler M; Herschenfeld A; Forsthuber T; Lehmann PV; Kaufman DL
J Exp Med; 1996 Apr; 183(4):1561-7. PubMed ID: 8666914
[TBL] [Abstract][Full Text] [Related]
2. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
[TBL] [Abstract][Full Text] [Related]
3. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
[TBL] [Abstract][Full Text] [Related]
4. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.
Zekzer D; Wong FS; Ayalon O; Millet I; Altieri M; Shintani S; Solimena M; Sherwin RS
J Clin Invest; 1998 Jan; 101(1):68-73. PubMed ID: 9421467
[TBL] [Abstract][Full Text] [Related]
5. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens.
Tian J; Lehmann PV; Kaufman DL
J Exp Med; 1997 Dec; 186(12):2039-43. PubMed ID: 9396773
[TBL] [Abstract][Full Text] [Related]
6. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
[TBL] [Abstract][Full Text] [Related]
7. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
8. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
9. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice.
Tian J; Clare-Salzler M; Herschenfeld A; Middleton B; Newman D; Mueller R; Arita S; Evans C; Atkinson MA; Mullen Y; Sarvetnick N; Tobin AJ; Lehmann PV; Kaufman DL
Nat Med; 1996 Dec; 2(12):1348-53. PubMed ID: 8946834
[TBL] [Abstract][Full Text] [Related]
10. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens.
Cetkovic-Cvrlje M; Gerling IC; Muir A; Atkinson MA; Elliott JF; Leiter EH
Diabetes; 1997 Dec; 46(12):1975-82. PubMed ID: 9392483
[TBL] [Abstract][Full Text] [Related]
11. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
Maron R; Melican NS; Weiner HL
J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
[TBL] [Abstract][Full Text] [Related]
12. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies.
Bockova J; Elias D; Cohen IR
J Autoimmun; 1997 Aug; 10(4):323-9. PubMed ID: 9237795
[TBL] [Abstract][Full Text] [Related]
13. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
14. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
Kaufman DL; Clare-Salzler M; Tian J; Forsthuber T; Ting GS; Robinson P; Atkinson MA; Sercarz EE; Tobin AJ; Lehmann PV
Nature; 1993 Nov; 366(6450):69-72. PubMed ID: 7694152
[TBL] [Abstract][Full Text] [Related]
16. Infectious Th1 and Th2 autoimmunity in diabetes-prone mice.
Tian J; Olcott AP; Hanssen LR; Zekzer D; Middleton B; Kaufman DL
Immunol Rev; 1998 Aug; 164():119-27. PubMed ID: 9795770
[TBL] [Abstract][Full Text] [Related]
17. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
Qin HY; Singh B
J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
[TBL] [Abstract][Full Text] [Related]
18. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice.
Petersen JS; Karlsen AE; Markholst H; Worsaae A; Dyrberg T; Michelsen B
Diabetes; 1994 Dec; 43(12):1478-84. PubMed ID: 7958502
[TBL] [Abstract][Full Text] [Related]
19. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
[TBL] [Abstract][Full Text] [Related]
20. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
Tisch R; Liblau RS; Yang XD; Liblau P; McDevitt HO
Diabetes; 1998 Jun; 47(6):894-9. PubMed ID: 9604865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
